N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide

C26H28FN5O3S — CID 118024001

IUPACN-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide
SMILESO=S(=O)(NC1CN(c2cc3c(cc2F)OCC(N2CCC2)C3Cc2ccccc2)C1)c1cccnn1
InChIInChI=1S/C26H28FN5O3S/c27-22-14-25-21(20(12-18-6-2-1-3-7-18)24(17-35-25)31-10-5-11-31)13-23(22)32-15-19(16-32)30-36(33,34)26-8-4-9-28-29-26/h1-4,6-9,13-14,19-20,24,30H,5,10-12,15-17H2
InChIKeyQGPFUUSJRANRFB-UHFFFAOYSA-N
MW509.61 g/mol
LogP2.58
Rot. Bonds7

About N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide

N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide (PubChem CID 118024001) has the molecular formula C26H28FN5O3S and a molecular weight of 509.61 g/mol. Its IUPAC name is N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide.

Molecular Properties

Compound NameN-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide
PubChem CID118024001
Molecular FormulaC26H28FN5O3S
Molecular Weight509.61 g/mol
Exact Mass509.19
IUPAC NameN-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide
SMILESO=S(=O)(NC1CN(c2cc3c(cc2F)OCC(N2CCC2)C3Cc2ccccc2)C1)c1cccnn1
InChIInChI=1S/C26H28FN5O3S/c27-22-14-25-21(20(12-18-6-2-1-3-7-18)24(17-35-25)31-10-5-11-31)13-23(22)32-15-19(16-32)30-36(33,34)26-8-4-9-28-29-26/h1-4,6-9,13-14,19-20,24,30H,5,10-12,15-17H2
InChIKeyQGPFUUSJRANRFB-UHFFFAOYSA-N
XLogP2.58
TPSA87.66 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500509.61
LogP ≤ 52.58
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}

Analyze N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide?
The IUPAC name of N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide (CID 118024001) is N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide.
What is the SMILES notation for N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide?
The canonical SMILES for N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide is O=S(=O)(NC1CN(c2cc3c(cc2F)OCC(N2CCC2)C3Cc2ccccc2)C1)c1cccnn1.
What is the InChIKey of N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide?
The InChIKey is QGPFUUSJRANRFB-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28FN5O3S/c27-22-14-25-21(20(12-18-6-2-1-3-7-18)24(17-35-25)31-10-5-11-31)13-23(22)32-15-19(16-32)30-36(33,34)26-8-4-9-28-29-26/h1-4,6-9,13-14,19-20,24,30H,5,10-12,15-17H2.
What are the key properties of N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide?
N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide has a molecular weight of 509.61 g/mol, XLogP of 2.58, 7 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[3-(azetidin-1-yl)-4-benzyl-7-fluoro-3,4-dihydro-2H-chromen-6-yl]azetidin-3-yl]pyridazine-3-sulfonamide is sourced from PubChem (CID 118024001), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).